Condition: Coronary Disease · Heart Diseases · Cardiovascular Diseases · Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS
This international, multicenter, open-label, randomized clinical trial evaluates the safety and efficacy of single antiplatelet therapy (SAPT) compared to dual antiplatelet therapy (DAPT) in elderly or high bleeding risk patients undergoing percutaneous coronary intervention (PCI) with the latest generation drug-coated balloon (DCB). The study includes patients with stable or unstable coronary syndromes and aims to assess rates of ischemic and bleeding adverse events.
This description comes directly from the study's public registry record.
Bernardo Cortese, MD MSc · 216-296-9747 · bcortese@gmail.com
Beatrice Barbano · segreteria@fondazioneric.org
Always discuss trial participation with your own doctor first.
| IRCCS Auxologico Milano | Milan, MI, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06535568